三亿体育官网 clinical trial will test precision medicine treatments for myeloid cancers
Wednesday, October 23, 2024
三亿体育官网 clinical trial will test precision medicine treatments for myeloid cancers
The National Institutes of Health (三亿体育官网) has launched a proof-of-concept precision medicine clinical trial to test new treatment combinations targeting specific genetic changes in the cancer cells of people with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The trial, funded by 三亿体育官网鈥檚 National Cancer Institute (NCI), aims to accelerate the discovery of more tailored treatments for these aggressive cancers of the blood and bone marrow.
鈥淣CI is uniquely positioned to conduct this type of study, which is one of a series of NCI precision medicine trials that are helping pave the way for more personalized treatment of cancer," said W. Kimryn Rathmell, M.D., Ph.D., director of NCI. "By making these trials available to patients in communities around the coun